RLMD
Price
$0.67
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
20.25M
44 days until earnings call
SNGX
Price
$1.36
Change
-$0.01 (-0.73%)
Updated
Jun 27 closing price
Capitalization
4.34M
Interact to see
Advertisement

RLMD vs SNGX

Header iconRLMD vs SNGX Comparison
Open Charts RLMD vs SNGXBanner chart's image
Relmada Therapeutics
Price$0.67
Change-$0.00 (-0.00%)
Volume$28.91K
Capitalization20.25M
Soligenix
Price$1.36
Change-$0.01 (-0.73%)
Volume$367.67K
Capitalization4.34M
RLMD vs SNGX Comparison Chart in %
Loading...
RLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RLMD vs. SNGX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLMD is a Hold and SNGX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (RLMD: $0.67 vs. SNGX: $1.36)
Brand notoriety: RLMD and SNGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RLMD: 1% vs. SNGX: 477%
Market capitalization -- RLMD: $20.25M vs. SNGX: $4.34M
RLMD [@Biotechnology] is valued at $20.25M. SNGX’s [@Biotechnology] market capitalization is $4.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RLMD’s FA Score shows that 1 FA rating(s) are green whileSNGX’s FA Score has 1 green FA rating(s).

  • RLMD’s FA Score: 1 green, 4 red.
  • SNGX’s FA Score: 1 green, 4 red.
According to our system of comparison, RLMD is a better buy in the long-term than SNGX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RLMD’s TA Score shows that 5 TA indicator(s) are bullish while SNGX’s TA Score has 4 bullish TA indicator(s).

  • RLMD’s TA Score: 5 bullish, 3 bearish.
  • SNGX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RLMD is a better buy in the short-term than SNGX.

Price Growth

RLMD (@Biotechnology) experienced а -0.80% price change this week, while SNGX (@Biotechnology) price change was -20.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

RLMD is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLMD($20.2M) has a higher market cap than SNGX($4.34M). RLMD YTD gains are higher at: 29.442 vs. SNGX (-49.536). SNGX has higher annual earnings (EBITDA): -10.78M vs. RLMD (-79.12M). RLMD has more cash in the bank: 27.1M vs. SNGX (7.3M). SNGX has less debt than RLMD: SNGX (79.1K) vs RLMD (256K). RLMD has higher revenues than SNGX: RLMD (0) vs SNGX (-117.03K).
RLMDSNGXRLMD / SNGX
Capitalization20.2M4.34M465%
EBITDA-79.12M-10.78M734%
Gain YTD29.442-49.536-59%
P/E RatioN/AN/A-
Revenue0-117.03K-
Total Cash27.1M7.3M371%
Total Debt256K79.1K324%
FUNDAMENTALS RATINGS
RLMD vs SNGX: Fundamental Ratings
RLMD
SNGX
OUTLOOK RATING
1..100
7150
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
22
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
4194
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RLMD's Valuation (20) in the null industry is in the same range as SNGX (22) in the Biotechnology industry. This means that RLMD’s stock grew similarly to SNGX’s over the last 12 months.

RLMD's Profit vs Risk Rating (100) in the null industry is in the same range as SNGX (100) in the Biotechnology industry. This means that RLMD’s stock grew similarly to SNGX’s over the last 12 months.

RLMD's SMR Rating (99) in the null industry is in the same range as SNGX (100) in the Biotechnology industry. This means that RLMD’s stock grew similarly to SNGX’s over the last 12 months.

RLMD's Price Growth Rating (41) in the null industry is somewhat better than the same rating for SNGX (94) in the Biotechnology industry. This means that RLMD’s stock grew somewhat faster than SNGX’s over the last 12 months.

RLMD's P/E Growth Rating (100) in the null industry is in the same range as SNGX (100) in the Biotechnology industry. This means that RLMD’s stock grew similarly to SNGX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RLMDSNGX
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 10 days ago
85%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
80%
Aroon
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
RLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NDAQ89.060.67
+0.76%
Nasdaq
PDM7.280.05
+0.69%
Piedmont Realty Trust Inc
AEIS132.31-1.53
-1.14%
Advanced Energy Industries
CLPT11.80-0.22
-1.83%
ClearPoint Neuro
VRAR1.30-0.03
-2.26%
Glimpse Group (The)

RLMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLMD has been loosely correlated with ENTO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if RLMD jumps, then ENTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLMD
1D Price
Change %
RLMD100%
N/A
ENTO - RLMD
35%
Loosely correlated
-12.87%
ARGNF - RLMD
31%
Poorly correlated
N/A
TPST - RLMD
26%
Poorly correlated
-2.68%
CYTK - RLMD
26%
Poorly correlated
-2.21%
SNGX - RLMD
25%
Poorly correlated
-0.73%
More

SNGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNGX has been closely correlated with ALLR. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if SNGX jumps, then ALLR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNGX
1D Price
Change %
SNGX100%
-0.73%
ALLR - SNGX
85%
Closely correlated
+2.12%
WINT - SNGX
82%
Closely correlated
+21.49%
RNAC - SNGX
81%
Closely correlated
-6.81%
NRXP - SNGX
81%
Closely correlated
-2.29%
CDTX - SNGX
81%
Closely correlated
+0.24%
More